Korean J Pain 2021; 34(1): 106-113
Published online January 1, 2021 https://doi.org/10.3344/kjp.2021.34.1.106
Copyright © The Korean Pain Society.
Sukhee Park1 , Joohyun Park2 , Ji Won Choi2 , Yu Jeong Bang2 , Eun Jung Oh2 , Jiyeon Park1 , Kwan Young Hong2 , Woo Seog Sim2
1Department of Anesthesiology and Pain Medicine, International St. Mary’s Hospital, Catholic Kwandong University School of Medicine, Incheon, Korea
2Department of Anesthesiology and Pain Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
Correspondence to:Ji Won Choi
Department of Anesthesiology and Pain Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 06351, Korea
Tel: +82-2-3410-6590
Fax: +82-2-3410-6626
E-mail: jiwon0715.choi@samsung.com
*These authors contributed equally to this work.
Received: September 2, 2020; Revised: November 18, 2020; Accepted: November 23, 2020
Background: We aimed to investigate the analgesic efficacy of an erector spinae plane block (ESPB) in immediate breast reconstruction (IBR) with a tissue expander.
Methods: Adult women undergoing IBR with a tissue expander after mastectomy were randomly assigned to either intravenous patient-controlled analgesia (IV-PCA) alone (group P) or IV-PCA plus ESPB (group E). The primary outcome was the total amount of opioid consumption during 24 hours postoperatively between the two groups. Secondary outcomes were patient satisfaction, pain score at rest and on shoulder movement using numerical rating scale, incidences of postoperative nausea and vomiting (PONV), and a short form of the brief pain inventory (BPI-SF) at 3 and 6 months after surgery between the groups.
Results: Fifty eight patients completed the study. At 24 hours postoperatively, total opioid consumption was significantly less in group E than in group P (285.0 ± 92.0, 95% confidence interval [CI]: 250.1 to 320.0 vs. 223.2 ± 83.4, 95% CI: 191.5 to 254.9, P = 0.005). Intraoperative and cumulative PCA fentanyl consumption at 3, 6, 9, and 24 hours were also less in group E than in group P (P = 0.004, P = 0.048, P = 0.020, P = 0.036, and P < 0.001, respectively). Patient satisfaction was higher in group E (6.9 ± 1.8 vs. 7.8 ± 1.4, P = 0.042). The incidences of PONV was similar.
Conclusions: The ESPB decreased postoperative opioid consumption and increased patient satisfaction without significant complications after IBR with a tissue expander after mastectomy.
Keywords: Analgesia, Breast Implants, Breast Neoplasms, Mastectomy, Nerve Block, Pain, Postoperative, Patient Satisfaction, Reconstructive Surgical Procedures, Tissue Expansion Devices, Ultrasonography, Interventional.